&l;p&g;&l;img class=&q;size-large wp-image-17&q; src=&q;http://blogs-images.forbes.com/rcarson/files/2018/04/GettyImages-688949102-1200×701.jpg?width=960&q; alt=&q;&q; data-height=&q;701&q; data-width=&q;1200&q;&g; Ask yourself: Am I&a;nbsp;financially prepared for retirement?
Becoming a first-time grandfather makes one acutely aware of the number of years left on this planet. Suddenly,....More>>>
Yesterday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biotech RXi Pharmaceuticals Corp (NASDAQ: RXII) as a long/bullish trade for our short-term portfolio:
RXi Pharmaceuticals was hit pretty hard in September and October, but we like the way the stock’s been piecing together the foundation for a technical breakout. That is, we’ve made a higher low,....More>>>
Immunogen Inc (NASDAQ:IMGN) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products. Immunogen Inc has a market cap of $1.54 billion; its shares were traded at around $11.65 with and P/S ratio....More>>>
Takeda Pharmaceutical Co. is nearing a preliminary agreement to acquire Shire Plc after the Japanese drugmaker sweetened its roughly $60 billion bid for the biotechnology company, according to people with knowledge of the matter.
Shire’s board “is considering its position” on a new bid, the company said in a statement Tuesday after Bloomberg News reported that the companies....More>>>
Royal Caribbean Cruises Ltd. (RCL) stock dropped on Thursday, April 26, as sales lagged expectations, but Chairman and CEO Richard Fain is bullish on the year ahead.
“We are seeing strong demand for our product, our new ships are blowing everyone away, I’m extremely encouraged that only for this travel season, but the 2019 and beyond timeframe as well,” Fain told TheStreet....More>>>